Mu‐Wen Lin

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Affiliated Hospital of Guangdong Medical College Hospital(Current)

Mu‐Wen Lin is an author at Affiliated Hospital of Guangdong Medical College Hospital specializing in immunotherapy biomarker selection, lung adenocarcinoma, and pharmacology.

Publications per year

2022–2022

Publications

Serum exosomal <scp>miR</scp>‐16‐5p functions as a tumor inhibitor and a new biomarker for <scp>PD‐L1</scp> inhibitor‐dependent immunotherapy in lung adenocarcinoma by regulating <scp>PD‐L1</scp> expression

Hua‐Lin Chen, Yi‐Ping Luo, Mu‐Wen Lin et al. · Cancer Medicine · 2022 · 36 citations · Full text

Medicine, Oncology, Pharmacology +17

1–1 of 1